| Biosimilar Insulins and Insulin Analogues Stand to Erode $6.1 Billion in Brand ... - Earthtimes (press release) |
|
|
Earthtimes (press release)Surveyed Nephrologists Are Not Completely Opposed to Prescribing a Biosimilar For an Indication in Which It Has Been Approved But Not Clinically Studied, ... read more |